Medicare Advantage in the Crosshairs
The 2025 edition of that yearly stressful period called “Annual Enrollment Period,” or AEP for short, ended just a few
Read MoreThe 2025 edition of that yearly stressful period called “Annual Enrollment Period,” or AEP for short, ended just a few
Read MoreJust when you thought the barrage of ads, commercials, and mail inserts was over, it starts all over again on
Read MoreMedicare spending on COVID-19 testing in 2022 outpaced 2020 and is expected to exceed 2021 spending as well, even though
Read More2023 is just around the corner…two days away, as a matter of fact…so now’s a good time to catch up
Read MoreConsolidation of hospitals has become a topic of focus in a number of quarters, nationally and locally. Related to that
Read MoreWell, we’re at that point of the year where Medicare’s 2023 costs are coming into focus. As a refresher, Salem
Read MoreThe 2022 KFF Employer Health Benefits Survey, a study focusing on over 2,000 interviews with non-federal public and private firms,
Read MoreAlthough increases in monthly premiums for Medicare Advantage plans are becoming more of the norm, it doesn’t seem to bother
Read MoreJapan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read MoreRemember when the most popular component of Medicare Advantage plans was the addition of a gym membership? It seems lately
Read More